Literature DB >> 31213677

A licence to kill during inflammation.

Kengo Nozaki, Edward A Miao.   

Abstract

Entities:  

Keywords:  Immunology; Structural biology

Mesh：

Substances：

Year:  2019        PMID： 31213677     DOI： 10.1038/d41586-019-01764-9

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages.

Authors:  Luigi Franchi; Amal Amer; Mathilde Body-Malapel; Thirumala-Devi Kanneganti; Nesrin Ozören; Rajesh Jagirdar; Naohiro Inohara; Peter Vandenabeele; John Bertin; Anthony Coyle; Ethan P Grant; Gabriel Núñez
Journal:  Nat Immunol       Date:  2006-04-30       Impact factor: 25.606

2.  Crystal structure of NLRC4 reveals its autoinhibition mechanism.

Authors:  Zehan Hu; Chuangye Yan; Peiyuan Liu; Zhiwei Huang; Rui Ma; Chenlu Zhang; Ruiyong Wang; Yueteng Zhang; Fabio Martinon; Di Miao; Haiteng Deng; Jiawei Wang; Junbiao Chang; Jijie Chai
Journal:  Science       Date:  2013-06-13       Impact factor: 47.728

3.  Structural and biochemical basis for induced self-propagation of NLRC4.

Authors:  Zehan Hu; Qiang Zhou; Chenlu Zhang; Shilong Fan; Wei Cheng; Yue Zhao; Feng Shao; Hong-Wei Wang; Sen-Fang Sui; Jijie Chai
Journal:  Science       Date:  2015-10-08       Impact factor: 47.728

4.  Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization.

Authors:  Liman Zhang; Shuobing Chen; Jianbin Ruan; Jiayi Wu; Alexander B Tong; Qian Yin; Yang Li; Liron David; Alvin Lu; Wei Li Wang; Carolyn Marks; Qi Ouyang; Xinzheng Zhang; Youdong Mao; Hao Wu
Journal:  Science       Date:  2015-10-08       Impact factor: 47.728

5.  A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation.

Authors:  Jonathan L Schmid-Burgk; Dhruv Chauhan; Tobias Schmidt; Thomas S Ebert; Julia Reinhardt; Elmar Endl; Veit Hornung
Journal:  J Biol Chem       Date:  2015-11-09       Impact factor: 5.157

Review 6.  Mitotic Regulation by NEK Kinase Networks.

Authors:  Andrew M Fry; Richard Bayliss; Joan Roig
Journal:  Front Cell Dev Biol       Date:  2017-12-01

7.  NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component.

Authors:  Hexin Shi; Ying Wang; Xiaohong Li; Xiaoming Zhan; Miao Tang; Maggy Fina; Lijing Su; David Pratt; Chun Hui Bu; Sara Hildebrand; Stephen Lyon; Lindsay Scott; Jiexia Quan; Qihua Sun; Jamie Russell; Stephanie Arnett; Peter Jurek; Ding Chen; Vladimir V Kravchenko; John C Mathison; Eva Marie Y Moresco; Nancy L Monson; Richard J Ulevitch; Bruce Beutler
Journal:  Nat Immunol       Date:  2015-12-07       Impact factor: 25.606

8.  NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.

Authors:  Yuan He; Melody Y Zeng; Dahai Yang; Benny Motro; Gabriel Núñez
Journal:  Nature       Date:  2016-01-27       Impact factor: 49.962
  8 in total
  3 in total

1.  Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction.

Authors:  Qiang Li; Hui Feng; Hongbo Wang; Yinghao Wang; Wenqing Mou; Guang Xu; Ping Zhang; Ruisheng Li; Wei Shi; Zhilei Wang; Zhie Fang; Lutong Ren; Yan Wang; Li Lin; Xiaorong Hou; Wenzhang Dai; Zhiyong Li; Ziying Wei; Tingting Liu; Jiabo Wang; Yuming Guo; Pengyan Li; Xu Zhao; Xiaoyan Zhan; Xiaohe Xiao; Zhaofang Bai
Journal:  EMBO Rep       Date:  2021-12-09       Impact factor: 8.807

Review 2.  Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?

Authors:  Abdullah Al Emran; Hsin-Yi Tseng; Mikaela C Coleman; Jessamy Tiffen; Stuart Cook; Helen M McGuire; Stuart Gallagher; Carl Feng; Peter Hersey
Journal:  Pigment Cell Melanoma Res       Date:  2020-02-20       Impact factor: 4.693

Review 3.  Physiological and Pathological Roles of Mammalian NEK7.

Authors:  Zhenzhen Sun; Wei Gong; Yue Zhang; Zhanjun Jia
Journal:  Front Physiol       Date:  2020-12-07       Impact factor: 4.566
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.